Modern Australian
The Times Real Estate

.

LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in the Macau Special Administrative Region (SAR) of China

SHANGHAI, CHINA, and PRINCETON, N. J., USA - Media OutReach - 12 May 2023 - LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, announced yesterday that CAMZYOS®(mavacamten) has received marketing approval for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) from the Pharmaceutical Administration Bureau of the Macau SAR.



"Hypertrophic cardiomyopathy is a cardiovascular disease that significantly impacts the quality of life of patients," said Dr. Xiuhua Feng, Consultant of Cardiology at Kiang Wu Hospital. "We are very pleased to see the approval of mavacamten in Macau, as it will bring hope to local patients living with this chronic and debilitating condition."

"Macau marks mavacamten's first approval in LianBio's licensed territories," said Yizhe Wang, Ph.D., Chief Executive Officer of LianBio. "This approval is a major milestone for patients in the region and demonstrates LianBio's commitment to accelerating patient access throughout Asia to innovative new treatments."

In April 2023, the China National Medical Products Administration (NMPA) accepted with Priority Review the New Drug Application for mavacamten for the treatment of adults with symptomatic oHCM.

In April 2023, LianBio announced positive topline results from the Phase 3 EXPLORER-CN trial investigating mavacamten for the treatment of Chinese patients with symptomatic oHCM. EXPLORER-CN met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in Valsalva left ventricular outflow tract (LVOT) gradient from baseline to week 30 compared to placebo (p
Hashtag: #LianBio #CAMZYOS

The issuer is solely responsible for the content of this announcement.

About Mavacamten

CAMZYOS(mavacamten) is the first and only cardiac myosin inhibitor approved by the U.S. FDA indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III oHCM to improve functional capacity and symptoms. It has also received regulatory approvals in Australia, Canada, Brazil, Switzerland and Macau. CAMZYOS is an allosteric and reversible inhibitor selective for cardiac myosin. CAMZYOS modulates the number of myosin heads that can enter "on actin" (power generating) states, thus reducing the probability of force producing (systolic) and residual (diastolic) cross-bridge formation. Excess myosin actin cross bridge formation and dysregulation of the super relaxed state are mechanistic hallmarks of HCM. CAMZYOS shifts the overall myosin population towards an energy sparing, recruitable, super relaxed state. In HCM patients, myosin inhibition with CAMZYOS reduces dynamic left ventricular outflow tract (LVOT) obstruction and improves cardiac filling pressures.

LianBio licensed rights from MyoKardia, now a wholly owned subsidiary of Bristol Myers Squibb, in August 2020 for the development and commercialization of mavacamten in Mainland China, Hong Kong, Macau, Taiwan, Thailand and Singapore. Mavacamten was granted Breakthrough Therapy Designation in China for the treatment of patients with oHCM in February 2022.

About Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is a chronic, progressive disease in which excessive contraction of the heart muscle and reduced ability of the left ventricle to fill can lead to the development of debilitating symptoms and cardiac dysfunction. HCM is estimated to affect one in every 500 people globally. The most frequent cause of HCM is mutations in the heart muscle proteins of the sarcomere. In both obstructive and non-obstructive HCM patients, exertion can result in fatigue or shortness of breath, interfering with a patient's ability to participate in activities of daily living. HCM has also been associated with increased risks of atrial fibrillation, stroke, heart failure and sudden cardiac death.

In China, there are an estimated 1.1 million to 2.8 million patients with HCM.

About LianBio

LianBio is a cross-border biotechnology company on a mission to bring transformative medicines to historically underserved patients in China and other Asian markets. Through partnerships with highly innovative biopharmaceutical companies around the world, LianBio is advancing a diversified portfolio of clinically validated product candidates with the potential to drive new standards of care across cardiovascular, oncology, ophthalmology, and inflammatory disease. LianBio is establishing an international infrastructure to position the company as a partner of choice with a platform to provide access to China and other Asian markets. For more information, please visit .

Taking It Up a Notch: How 12.5kg Dumbbells Fit Into Progressive Overload Training

Photo by Jason Grant on Unsplash When it comes to getting stronger, more sculpted, and better conditioned, one principle reigns supreme in the worl...

Behind the Bowl: What Makes Premium Dog Food Worth the Price Tag?

Photo by Ayla Verschueren on Unsplash When it comes to feeding our four-legged companions, the pet food aisle can be a maze of options—bags promi...

Davines Sustainable Haircare: Revolutionizing Eco-Friendly Beauty Solutions

Davines is a well-known brand in the world of haircare, known for its high-quality products that deliver exceptional results. Its commitment to sust...

The Role of CDNs in Enhancing Headless CMS Performance and Reliability

A headless CMS provides businesses with the ultimate freedom for content management and output possibilities across any number of channels. However...

Finding the Right Dentist in Perth for Your Dental Implants: A Complete Guide

Missing teeth can significantly impact your quality of life, affecting everything from your ability to eat and speak to your self-confidence. Dental...

Fix These 5 Technical SEO Issues Hurting Your Perth Business Rankings

Perth businesses face unique challenges when competing for visibility in local search results.  While many business owners focus on content creati...

How a Professional Bookkeeper Can Help Your Small Business

Running a small business in Australia comes with many responsibilities, from managing day-to-day operations to ensuring compliance with tax and fina...

How Pre-Employment Drug Testing Can Improve Your Company’s Culture

When it comes to curating a thriving workplace, culture is everything. It is the glue holding teams together, the driving force behind productivity...

How To Find Comfortable And Stylish Armchairs Online

Shopping online can be tricky, particularly when it comes to buying furniture. All homeowners, including you, want an armchair that is stylish and c...

Rope Rescue Training Explained: Techniques, Tools & Skills

Rope rescue training is critical for emergency responders, industrial workers, and anyone who operates in high-risk environments. Whether you're a fir...

The Different Career Paths in a Law Firm: From Clerk to Partner

The legal profession offers a structured yet diverse career path, with opportunities ranging from entry-level positions to esteemed leadership roles...

The Importance of Exercise for People with Disabilities: Adaptive Workouts

Exercise is a fundamental part of maintaining physical and mental wellbeing, and this holds true for people of all abilities. For individuals with d...

Planning a Construction or Renovation? Don’t Overlook the Plumbing!

Building or renovating your home is an exciting journey—designing layouts, selecting finishes, and watching your space come to life. However, while ...

Bathroom Tiling: Trends, Materials and Installation Tips

The world of bathroom tiling has come a long way, with new trends, improved materials, and innovative installation techniques, making it easier than...

Best Products to Increase Hair Density: What Really Works?

Do you want thick, voluminous hair? We get you!! There’s just something about a full head of hair that makes you feel more confident. But what do...

The Cost of Back to Base Security in Sydney: Is It Worth the Investment?

Sydney is a fantastic place to live. The beaches, the cafes, the culture. There’s a reason people are willing to pay premium prices for a spot in ...

Australian Workplace Engagement Declines Amidst Shifting Employee Priorities

Global leader in employee engagement and HR technology, Reward Gateway, has today released its second annual Workplace Engagement Index. The report...

The Right Mix: 5 Tips for Choosing Products Your Customers Will Love

Photo: Marcella Marcella / Unsplash Crafting the perfect product offering is difficult. You need to strike a delicate balance between building a busi...